HSBC Holdings’s Compugen CGEN Stock Holding History

HSBC Holdings’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-15,995	Closed	-$193K	–	2775
2020 Q4	$193K	Buy	+15,995	New	+$221K	﹤0.01%	2833

Other funds holding CGEN

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HSBC Holdings's CGEN Position: Q1 2021 in Review

HSBC Holdings sold out of Compugen (CGEN) in Q1 2021, closing a stake of 15,995 shares — an estimated $193K sold.

HSBC Holdings first reported a position in CGEN in Q4 2020 and held it in 1 quarter. The position peaked at $193K in Q4 2020. 108 funds tracked by Wall St. Rank hold CGEN as of Q1 2021.

HSBC Holdings reported no remaining Compugen position as of Q1 2021 after selling out during the quarter.
HSBC Holdings sold 15,995 Compugen shares in Q1 2021, an estimated $193K.
HSBC Holdings first reported a position in Compugen in Q4 2020 and held it in 1 quarter.
HSBC Holdings's Compugen position peaked at $193K in Q4 2020.
108 funds tracked by Wall St. Rank held Compugen as of Q1 2021.

Based on HSBC Holdings's 13F filing for Q1 2021, filed 14 May 2021.